Quadriga Biosciences, Inc.   Report issue

For profit Phase 1
Founded: Los Altos CA United States (2010)

Organization Overview

First Clinical Trial
2020
NCT04430842
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Quadriga Biosciences, Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

qbs10072s (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 1)

Brain Neoplasms (Phase 1)

Cholangiocarcinoma (Phase 1)

Esophageal Neoplasms (Phase 1)

Mesothelioma (Phase 1)

Neoplasm Metastasis (Phase 1)

Thymoma (Phase 1)

Tongue Neoplasms (Phase 1)

Urologic Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1